Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1049645 | 0.88 | TAAR1 (0.61) | TAAR1MAOB | |
| Hydrochloric Acid SCHEMBL14157305 | 0.86 | TAAR1 (0.59) | TAAR1MAOB | |
| SCHEMBL5702512 | 0.82 | PPARA (0.47) | PPARAHTR2AESR1 | |
| SCHEMBL2024806 | 0.81 | SLC7A5 (0.48) | TAAR1MAOB | |
| SCHEMBL9479738 | 0.81 | PPARA (0.50) | PPARAPPARGCALM1 | |
| SCHEMBL18745376 | 0.81 | PPARA (0.46) | TAAR1PPARAPPARGCALM1 | |
| SCHEMBL9165832 | 0.81 | PPARA (0.46) | TAAR1PPARAPPARGCALM1 | |
| SCHEMBL6398359 | 0.81 | PPARA (0.46) | TAAR1PPARAPPARGCALM1 | |
| SCHEMBL3451212 | 0.81 | PPARA (0.68) | PPARAPPARGCALM1 | |
| SCHEMBL9165829 | 0.81 | PPARA (0.46) | TAAR1PPARAPPARGCALM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | TAAR1 2975/4885PPARA 3450/4885MAOB 4698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.